Literature DB >> 1346912

Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy.

W Ayliffe, M Haeney, S C Roberts, M Lavin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1346912     DOI： 10.1016/0140-6736(92)90385-g

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Adverse effects of intravenous immunoglobulin therapy.

Authors:  U E Nydegger; M Sturzenegger
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

2.  Atypical C-ANCA following high dose intravenous immunoglobulin.

Authors:  S Jolles; S Deacock; W Turnbull; R Silvestrini; C Bunn; P White; M Ward
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

3.  Early experience with intravenous immunoglobulin treatment in Wegener's granulomatosis with ocular involvement.

Authors:  M Blum; K Andrassy; D Adler; M Hartmann; H E Völcker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

Review 4.  Side-effects of intravenous immune globulins.

Authors:  C Duhem; M A Dicato; F Ries
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

5.  Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity.

Authors:  Thomas Grüter; Anthonina Ott; Wolfgang Meyer; Sven Jarius; Markus Kinner; Jeremias Motte; Kalliopi Pitarokoili; Ralf Gold; Lars Komorowski; Ilya Ayzenberg
Journal:  J Neurol       Date:  2019-11-14       Impact factor: 4.849

6.  Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice.

Authors:  I Krause; M Blank; Y Shoenfeld
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

Review 7.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

8.  Uveitis and anti-neutrophil cytoplasmic antibodies.

Authors:  E C Hagen; H van de Vijver-Reenalda; R J de Keizer; A Kijlstra; L A van Es; M R Daha; F J van der Woude
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

Review 9.  Adverse effects of intravenous immunoglobulin.

Authors:  S A Misbah; H M Chapel
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

Review 10.  Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.

Authors:  R Luqmani; C Gordon; P Bacon
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.